Author: Vergara, Ander; Molina-Van den Bosch, Mireia; Toapanta, Néstor; Villegas, Andrés; Sánchez-Cámara, Luis; de Sequera, Patricia; Manrique, JoaquÃn; Shabaka, Amir; Aragoncillo, Inés; Ruiz, MarÃa Carmen; Benito, Silvia; Sánchez, Emilio; Soler, MarÃa José
Title: The Impact of Age on Mortality in Chronic Haemodialysis Population with COVID-19 Cord-id: lejrs7xm Document date: 2021_7_7
ID: lejrs7xm
Snippet: Age and chronic kidney disease have been described as mortality risk factors for coronavirus disease 2019 (COVID-19). Currently, an important percentage of patients in haemodialysis are elderly. Herein, we investigated the impact of age on mortality among haemodialysis patients with COVID-19. Data was obtained from the Spanish COVID-19 chronic kidney disease (CKD) Working Group Registry. From 18 March 2020 to 27 August 2020, 930 patients on haemodialysis affected by COVID-19 were included in the
Document: Age and chronic kidney disease have been described as mortality risk factors for coronavirus disease 2019 (COVID-19). Currently, an important percentage of patients in haemodialysis are elderly. Herein, we investigated the impact of age on mortality among haemodialysis patients with COVID-19. Data was obtained from the Spanish COVID-19 chronic kidney disease (CKD) Working Group Registry. From 18 March 2020 to 27 August 2020, 930 patients on haemodialysis affected by COVID-19 were included in the Registry. A total of 254 patients were under 65 years old and 676 were 65 years or older (elderly group). Mortality was 25.1% higher (95% CI: 22.2–28.0%) in the elderly as compared to the non-elderly group. Death from COVID-19 was increased 6.2-fold in haemodialysis patients as compared to the mortality in the general population in a similar time frame. In the multivariate Cox regression analysis, age (hazard ratio (HR) 1.59, 95% CI: 1.31–1.93), dyspnea at presentation (HR 1.51, 95% CI: 1.11–2.04), pneumonia (HR 1.74, 95% CI: 1.10–2.73) and admission to hospital (HR 4.00, 95% CI: 1.83–8.70) were identified as independent mortality risk factors in the elderly haemodialysis population. Treatment with glucocorticoids reduced the risk of death (HR 0.68, 95% CI: 0.48–0.96). In conclusion, mortality is dramatically increased in elderly haemodialysis patients with COVID-19. Our results suggest that this high risk population should be prioritized in terms of protection and vaccination.
Search related documents:
Co phrase search for related documents- acute illness and long hospital stay: 1
- acute illness and long hospitalization: 1, 2, 3
- acute illness and lopinavir ritonavir: 1, 2, 3, 4, 5, 6
- acute illness and low mortality: 1, 2, 3, 4, 5, 6, 7, 8
- acute respiratory syndrome and admit patient: 1
- acute respiratory syndrome and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome and long hospital stay: 1, 2, 3
- acute respiratory syndrome and long hospitalization: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- acute respiratory syndrome and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome and low mortality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome and lymphopenia frequent: 1, 2
- logistic regression and long hospital stay: 1, 2, 3, 4, 5, 6, 7, 8
- logistic regression and long hospitalization: 1, 2, 3, 4, 5, 6, 7, 8, 9
- logistic regression and long hospitalization stay: 1
- logistic regression and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- logistic regression and low mortality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- long hospitalization and low mortality: 1
- lopinavir ritonavir and low mortality: 1, 2, 3, 4, 5, 6, 7, 8
- lopinavir ritonavir and lymphopenia frequent: 1, 2, 3, 4
Co phrase search for related documents, hyperlinks ordered by date